Genotypic characterization of Haemophilus influenzae isolates from paediatric patients in Japan

References

1. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20:368–389 [View Article][PubMed]
   [Google Scholar]
2. Agrawal A, Murphy TF. Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol 2011; 49:3728–3732 [View Article][PubMed]
   [Google Scholar]
3. Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J 2009; 28:43–48 [View Article][PubMed]
   [Google Scholar]
4. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302–317 [View Article][PubMed]
   [Google Scholar]
5. Briere EC, Rubin L, Moro PL, Cohn A, Clark T et al. Prevention and control of Haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2014; 63:1–14[PubMed]
   [Google Scholar]
6. Shinjoh M, Iwata S, Yagihashi T, Sato Y, Akita H et al. Recent trends in pediatric bacterial meningitis in Japan–a country where Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines have just been introduced. J Infect Chemother 2014; 20:477–483 [View Article][PubMed]
   [Google Scholar]
7. Ubukata K, Chiba N, Morozumi M, Iwata S, Sunakawa K et al. Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000–2011. J Infect Chemother 2013; 19:34–41 [View Article][PubMed]
   [Google Scholar]
8. Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R et al. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol 2003; 41:1623–1636 [View Article][PubMed]
   [Google Scholar]
9. Hoshino T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K et al. Nationwide survey of the development of drug resistance in the pediatric field in 2007 and 2010: drug sensitivity of Haemophilus influenzae in Japan (second report). J Infect Chemother 2013; 19:495–503 [View Article][PubMed]
   [Google Scholar]
10. Erwin AL, Sandstedt SA, Bonthuis PJ, Geelhood JL, Nelson KL et al. Analysis of genetic relatedness of Haemophilus influenzae isolates by multilocus sequence typing. J Bacteriol 2008; 190:1473–1483 [View Article][PubMed]
    [Google Scholar]
11. Giufrè M, Daprai L, Cardines R, Bernaschi P, Ravà L et al. Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy. Vaccine 2015; 33:6227–6234 [View Article][PubMed]
    [Google Scholar]
12. Kakuta R, Yano H, Hidaka H, Kanamori H, Endo S et al. Molecular epidemiology of ampicillin-resistant Haemophilus influenzae causing acute otitis media in Japanese infants and young children. Pediatr Infect Dis J 2016; 35:501–506 [View Article][PubMed]
    [Google Scholar]
13. Kaur R, Chang A, Xu Q, Casey JR, Pichichero ME. Phylogenetic relatedness and diversity of non-typable Haemophilus influenzae in the nasopharynx and middle ear fluid of children with acute otitis media. J Med Microbiol 2011; 60:1841–1848 [View Article][PubMed]
    [Google Scholar]
14. Morozumi M, Chiba N, Okada T, Sakata H, Matsubara K et al. Antibiotic susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae responsible for community-acquired pneumonia in children. J Infect Chemother 2013; 19:432–440 [View Article][PubMed]
    [Google Scholar]
15. Ubukata K, Morozumi M, Chiba N, Hamano-Hasegawa K. Real-time PCR detection of causative microorganisms in pediatric patients with acute otitis media in clinical phase III tebipenem-pivoxil studies. Jpn J Chemother 2009; 57:49–57
    [Google Scholar]
16. Japan Otological Society, Japan Society for Pediatric ORL, Japan Society for Infection and Aerosol in Otorhinolaryngology Clinical Practice Guidelines for The diagnosis and Management of Acute Otitis Media (Aom) in Children in Japan (Japanese), 1st ed. Tokyo, Japan: Kanehara & Co., Ltd; 2006
    [Google Scholar]
17. Morozumi M, Nakayama E, Iwata S, Aoki Y, Hasegawa K et al. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol 2006; 44:1440–1446 [View Article][PubMed]
    [Google Scholar]
18. Hasegawa K, Yamamoto K, Chiba N, Kobayashi R, Nagai K et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist 2003; 9:39–46 [View Article][PubMed]
    [Google Scholar]
19. Ubukata K, Asahi Y, Yamane A, Konno M. Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbiol 1996; 34:592–596[PubMed]
    [Google Scholar]
20. Hasegawa K, Chiba N, Kobayashi R, Murayama SY, Iwata S et al. Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob Agents Chemother 2004; 48:1509–1514 [View Article][PubMed]
    [Google Scholar]
21. Wajima T, Seyama S, Nakamura Y, Kashima C, Nakaminami H et al. Prevalence of macrolide-non-susceptible isolates among β-lactamase-negative ampicillin-resistant Haemophilus influenzae in a tertiary care hospital in Japan. J Glob Antimicrob Resist 2016; 6:22–26 [View Article][PubMed]
    [Google Scholar]
22. Hasegawa K, Kobayashi R, Takada E, Ono A, Chiba N et al. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother 2006; 57:1077–1082 [View Article][PubMed]
    [Google Scholar]
23. Kishii K, Morozumi M, Chiba N, Ono A, Ubukata K. Direct detection by real-time PCR of ftsI gene mutations affecting MICs of β-lactam agents for Haemophilus influenzae isolates from meningitis. J Infect Chemother 2011; 17:671–677 [View Article][PubMed]
    [Google Scholar]
24. Erwin AL, Nelson KL, Mhlanga-Mutangadura T, Bonthuis PJ, Geelhood JL et al. Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun 2005; 73:5853–5863 [View Article][PubMed]
    [Google Scholar]
25. Andersson M, Resman F, Eitrem R, Drobni P, Riesbeck K et al. Outbreak of a beta-lactam resistant non-typeable Haemophilus influenzae sequence type 14 associated with severe clinical outcomes. BMC Infect Dis 2015; 15:581 [View Article][PubMed]
    [Google Scholar]
26. Skaare D, Anthonisen IL, Caugant DA, Jenkins A, Steinbakk M et al. Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae. BMC Microbiol 2014; 14:131 [View Article][PubMed]
    [Google Scholar]
27. Tsang RSW, Shuel M, Whyte K, Hoang L, Tyrrell G et al. Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014. J Antimicrob Chemother 2017; 72:1314–1319 [View Article][PubMed]
    [Google Scholar]